An angiographic or diagnostic catheter is a tubular device that can be inserted into the anatomical cavity or blood vessels to allow fluid passage from or into a body cavity or blood vessel. According to BlueQuark the Global Angiographic Catheters Market is expected to grow considerably during the forecasted period. Factors such as the surging incidence of cardiovascular diseases and heart surgeries are expected to drive the Global Angiographic Catheters Market in the forecasted period. Further, developing new multi-speciality hospitals is expected to drive the global Angiography Catheters Market in the forecasted period. Furthermore, technological innovation in medical devices and increasing investments in the healthcare sector are driving the growth of the global Angiography Catheters Market in the forecasted period. However, the unconventional nature of therapies and their low availability will act as a restraint and further impede the growth rate of the Angiographic Catheters market in the forecast period.

Angiography catheters are used in diagnostic and therapeutic procedures, such as angiograms, to visualize the blood vessels and diagnose conditions such as coronary artery disease, peripheral artery disease, and aneurysms.

The increasing prevalence of cardiovascular diseases, which led to a growing need for early diagnosis and treatment, is predicted to drive the growth of the angiographic catheter market. The rising incidence of cardiovascular conditions such as peripheral artery disease, coronary artery disease, and heart attacks has led to a growing need for diagnostic and interventional procedures. Angiographic catheters are essential in performing angiography to visualize and assess blood vessels, aiding in diagnosing and treating these diseases. It allows a clearer inner image of blood arteries, allowing for the estimation of their morphology and the recognition of potential disorders such as arteriosclerosis or aneurysms. An angiographic catheter can evaluate the presence of aberrant blood arteries or blood flow in a particular location blocked or constrained by a tumour. This examination helps identify malignancies that may have grown on the blood vessel walls. Depending on the ailment being sought to recognize, this test can be performed in several locations on the body, including the brain, heart, or lungs.

An angiographic procedure uses a plastic tube known as an angiography catheter. The angiography catheter's primary function is to deliver therapeutic agents and radiopaque material into the body. The catheter tip can be made straight. Inserting the catheter tip into the sheath is more straightforward if straightened. A guidewire can be guided to the desired location using the implanted or pigtail catheter. A catheter and a small plastic conduit are introduced into a vein through a tiny skin scrape during catheter angiography. Medical professionals typically use angiographic catheters to locate aneurysms, diagnose artery disease, or direct interventional radiologists and surgeons. At the same time, they treat sick blood vessels by implanting stents or monitoring the state of a stent that has already been placed.

Rapid technological innovations in medical devices and increased government expenses for the edifice of healthcare infrastructure are major factors for boosting the market. Consumers are progressively persuaded to cuddle advanced healthcare apparatuses due to rising disposable income, increased spending capability, and beneficial reimbursement policies. A substantial upsurge in catheterization labs, a growing fondness for slightly invasive procedures, and an increase in cardiovascular disease cases are other factors boosting the market's growth.

North America holds a considerable share of the market due to the high disease burden, access to modern healthcare infrastructure, increased penetration of technological advancements, and favourable reimbursement policies for cardiac diseases. The hospital segment is expected to dominate the overall angiographic catheter market. The factors attributing to the dominance of this segment are enhanced healthcare infrastructure, availability of skilled labour, and affordability. The rise in the patient pool, owing to considerable growth in the geriatric population suffering from lifestyle diseases like atherosclerosis and heart failure, is expected to enhance revenue generations of the hospitals. Similarly, with the rising burden of infections caused by unhealthy lifestyles, like obesity, being overweight is predicted to drive the market's growth.

Balloon Pulmonary Angioplasty (BPA) catheter effectively treats Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Before stent placement or using Drug-coated Balloon angioplasty, Scoring Balloon Angioplasty for lumen gain is a critical interventional technique for lesion preparation. Recent research suggests that SBA could be important for enhancing the angiographic and therapeutic results of DCB angioplasty. The cutting balloon is an innovative angioplasty tool used in percutaneous coronary procedures. The advantage of the cutting balloon is its capacity to inhibit the uncontrolled breakup of the atherosclerotic plaque and limit vascular stretch and scratch by slicing the vessel longitudinally. The atherotomes supply a controlled fault line. Lower balloon inflation pressures are advised with the cutting balloon. In addition, the cutting balloon uses reduced force to dilate the target vessel, decreasing the chance of a non-proliferative reaction and in-stent restenosis, hence driving revenue growth of this segment.

The market key players are Medtronic, AngioDynamics, Boston Scientific Corporation, Cook Medical, and Cordis.

In February 2022, Teleflex received Food and Drug Administration clearance for an expanded indication for speciality catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions.

In April 2023, Terumo Corporation announced the launch of its new Safeslip hydrophillic angiographic catheter. The Safeslip catheter is designed to be less likely to cause vascular spasms than traditional angiographic catheters.

Global Angiographic Catheters Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Angiographic Catheters Market by segmenting based on Product (Conventional Catheters, Eluting Balloon Catheters, Cutting Balloon Catheters, Scoring Balloon Catheters), Application (Coronary, Endovascular, Neurology, Oncology), Technology (X-Ray, MRA, CT), End User (Hospital, Ambulatory Surgical Centers, Cardiac Centers, Brain Centers, Specialty Clinics, Others), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East & Africa). The report examines the market drivers and restraints and the impact of COVID-19 on market growth in detail. The study covers emerging market trends, development, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.